Results 201 to 210 of about 122,177 (317)

Medicines for Anxiety: A Hundred Years of Tranquillity and More to Come?

Human Psychopharmacology: Clinical and Experimental, Volume 41, Issue 2, March 2026.
David Nutt
wiley   +1 more source

Alcohol Use Disorder With Metabolic Dysfunction Is Associated With Adverse Health Impacts in a United States Clinical Setting

Addiction Biology, Volume 31, Issue 3, March 2026.
This study contributes to understanding the health impacts of co‐occurring alcohol use disorder (AUD) and metabolic dysfunction (MD). Using clinical data from the NIH, individuals with both AUD and MD (metAUD) had the strongest associations with greater hepatic injury and inflammation, a less favorable liver function test profile, higher fibrosis ...
Alexandra C. Wagner, Jeesun Jung, Joshua Reitz, Tyler Perlstein, LaToya Sewell, Melanie L. Schwandt, Nancy Diazgranados, Josephin Wagner, Daniel B. Rosoff, Falk W. Lohoff   +9 more
wiley   +1 more source

Exploring the Theoretical Potential of Benzphetamine in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). [PDF]

Cureus
Kothari PM, Singer DP.
europepmc   +1 more source

Amphetamine Users in Australia: Population Trends

, 2003
Agrawal, Manju R., C. Yalçın Kaya, Filar, Jerzy A.   +2 more
openalex   +1 more source

Physical exercise reduces behavioral and molecular parameters involved in amphetamine drug addiction in rat: involvement of the endogenous opioid pathway [PDF]

, 2023
Higor Zuquetto Rosa
openalex  

Characteristics of methamphetamine‐related deaths in the United Kingdom, 1997–2024

Addiction, Volume 121, Issue 3, Page 680-685, March 2026.
Abstract Background and aims People who use methamphetamine have a standardised mortality ratio 6.8 times greater than the general population, with several countries reporting concerning increases in methamphetamine‐related mortality over the past decade.
Emmert Roberts, Rebecca McKetin, Caroline Copeland   +2 more
wiley   +1 more source

Prevalence of Illicit Drug Detection in 5 US Cities Among Out-of-Treatment People Who Inject Drugs. [PDF]

JAMA Netw Open
El-Bassel N, Shoptaw S, Skalland T, Hanscom B, Clarke W, Marzinke MA, Fogel JM, Richardson P, Choudhury RP, Denis C, Goodman-Meza D, Kuo I, Lake JE, Morrison EAB, Richards AM, Harris-Wisecarver J, Cummings M, Chandler R, Andrew P, HPTN 094 Study Team.   +19 more
europepmc   +1 more source

Cocaine- and Amphetamine-Regulated Transcript (CART) Is Colocalized with the Orexigenic Neuropeptide Y and Agouti-Related Protein and Absent from the Anorexigenic α-Melanocyte-Stimulating Hormone Neurons in the Infundibular Nucleus of the Human Hypothalamus [PDF]

, 2007
Judit Menyhért, Gábor Wittmann, Ronald M. Lechan, Éva Keller, Zsolt Liposits, Csaba Fekete   +5 more
openalex   +1 more source

Rare but relevant: MDMA and hyponatraemia

Addiction, Volume 121, Issue 3, Page 713-718, March 2026.
Abstract Conventionally used for its stimulant, empathogenic and entactogenic effects, 3,4‐methylenedioxymethamphetamine (MDMA, ecstasy) is one of the most commonly used psychoactive drugs, specifically among young adults and in nightlife and recreational party contexts.
Maria Rita Garcia, Nelson G. M. Gomes, Diana Dias‐da‐Silva   +2 more
wiley   +1 more source

Analysis of β-Methylphenethylamine (BMPEA) and Its Novel Metabolites in Rat Blood Using MMSPE and UPLC-qTOF-MS. [PDF]

Toxics
Alamir A, Watterson J, Attafi I.
europepmc   +1 more source